evok longas you see in the chart it seems there is Adam and Eve pattern if evok broken 3.5 in high volume . hope will seebig jump to around7.5$
EVOK trade ideas
Evoke Pharma gone Woke. EVOKThese pharma stocks are dropping like flies.
Immediate targets 0.29, 0.16. Invalidation at 0.83
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe
EVOK LongPrice above SMA13
OBV>OBV34
WR > -80
Entry 1.4
Stop 1
Target 3.7
Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.
EVOK (NASDAQ) - Wait and SeeGreetings
Humbled, we would like to thanks for your support who has already liked, commented and followed us. Your support, strengthens us, to help in analyzing the market. If you have any questions, feel free to send us message (inbox).
Pra Trading :
- Please care for Money Management
- Have a good psychology
- Do not be hurry to open position and do not do nothing if u see opportunity
- Evaluate and upgrade your trading plan
Execution Strategy :
- Know what you want to buy, see the Fundamental
- Decide that you are on investing or speculating
- Consider what your strategy based on Investing/Speculating
- Make Road Map Of Your Trading Plan
- Decide
a. Entry strategy
b. Cut loss
c. Target of Profit
Post Trading :
a. Do not be sad if you loss or do not be very happy if you win
b. Just become a normal without emotion, Do not put emotion into your trading
c. Evaluate your trading
d. Keep on Learning
e. Be Humble
Idea :
EVOK (NASDAQ) - Wait and See
EVOK: Goes up when everything else goes down...EVOK has an analyst sell target at $10. I believe that with a float of 24M, this stock has the stock characteristics to hit $10 and maybe even further. And why is it positive when everything else is down???
$EVOK- Evoke Pharma IncWOW, looks pretty cool. Do I want it though, not right now, no...
Its starting to build up is how I look at it. From 3.75 to 4.15 is amazing buying power for you to actually make some AMAZING gains....
Invest Smart
Can't predict the future but it looks promising...
FDA Approves Evoke’s GIMOTI™We are extremely pleased to have received FDA approval to commercially market GIMOTI in the United States. This approval represents the first novel pharmaceutical treatment for gastroparesis in several decades. We are excited to be able to offer health care providers and their patients a unique non-oral treatment option to relieve symptoms and help improve their quality of life.
“ Together with our partner EVERSANA, we are now fully focused on executing our commercialization strategy for GIMOTI by leveraging EVERSANA’s integrated suite of capabilities and highly experienced sales and marketing team,” continued David Gonyer, R.Ph. “We anticipate initiating commercial sales in the fourth quarter of 2020 .”
The FDA approval of GIMOTI allows Evoke to access its existing $5 million line of credit from EVERSANA to support manufacturing and other aspects of GIMOTI’s commercialization. As of May 31, 2020, the Company’s cash and cash equivalents were approximately $4.7 million. Evoke believes, based on its current operating plan, that its cash and cash equivalents, together with the EVERSANA line of credit, will support the company’s operations into 2021, without consideration of potential GIMOTI revenue.
www.globenewswire.com
FDA Approves Evoke’s GIMOTI™!!!EVOK: Evoke Pharma, Inc.
2020-06-19 15:32:10
FDA Approves Evoke’s GIMOTI™
EVOK - MA200 Holding - Momentum IncreasingEvoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.
SHORT INTEREST
585.77K 09/13/19
P/E Current
-1.80
P/E Ratio (with extraordinary items)
-2.60
Average Recommendation: HOLD
Average Target Price: 9.00
Unusual Accumulation in EVOKE PHARMA INC. Keep watchKeep on your watchlist for continuation in price action and buy side volume, looks like accumulation is underway and the fact it is a Pharmaceutical stock, Trial data or FDA releases could be the stimulus.
Very speculative, but very rewarding trade setup on the chart.
COMPANY PROFILE
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.
EVOK - Long if above 3.60In case EVOK raises above 3.60, it may be a potential good buy. I added an alert around $3.50
Evok - long breakouts Volume has been coming in very nicely off this double bottom watch for breakouts
EVOK POTENTIAL WAVE UPEVOK is in a strong downtrend but it seems breaking this descending channel. If the level posted on chart holds it can make one more wave up. A strong breakdown under the rectangle on chart invalidates this setup.
EVOK Trend Downwards?It looks like EVOK could continue the same pattern downwards. The question is has it hit a base that is more of a foundation than the other three before it, or will is the final foundation further down?
